Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Esophageal Neoplasms × tegafur-gimeracil-oteracil × Clear all

Phase

Phase 2 2 Phase 2/3 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 1 Patients With Advanced or Metastatic Solid Tumors 1 Esophageal Neoplasms 1

Interventions

Paclitaxel 16 Fluorouracil 15 Cisplatin 15 Carboplatin 15 pembrolizumab 14 Irinotecan 11 Radiotherapy 10 Oxaliplatin 10 Cyclophosphamide 10 Capecitabine 9 Leucovorin 8 Radiation 7 Docetaxel 7 fludarabine 6 Gemcitabine 6 Trastuzumab 5 Taxes 5 fludarabine phosphate 4 LY6K protein, human 4 Fluorodeoxyglucose F18 4 Erlotinib Hydrochloride 4 Bevacizumab 4 spartalizumab 3 aldesleukin 3 Surgical Procedures, Operative 3 S 1 (combination) 3 Pemetrexed 3 Nivolumab 3 Drug Therapy 3 zimberelimab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02347904 2019-11-18

SOX

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 1 Completed

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡